Substance use treatment providers, clinicians, outreach workers, and public health clinics should be aware of the following information.
Safety Alerts
csfre: New Nitazene Analoguie N-Pyrrolidino Protonitazene Impacting Drug Markets in North America and Europe

The objective of this announcement is to notify public health and safety, law enforcement, first responders, clinicians, medical...
Substance abuse treatment providers, clinicians, outreach workers, and public health clinics should be aware of the following information. Quetiapine...
Captagon®, the trade name for fenethylline, an amphetamine prodrug, was originally developed by a German company in 1961 as...
NADDI received a Special Alert on a rather unusual incident that occurred involving a last-mile courier robbery that is...
LIR: Targeting of Medical Office Electronic Protected Health Information by Malicious Threat Actors

The FBI Las Vegas Field Office, in coordination with the Office of Private Sector, prepared this Liaison Information Report...
The Center for Forensic Science Research and Education (CFSRE) at the Fredric Rieders Family Foundation (FRFF) in conjunction with...
LIR: Criminal Actors Diverting Tramadol for Use as an Adulterant in Illicit Narcotics

Criminal Actors Diverting Tramadol for Use as an Adulterant in Illicit Narcotics: The FBI’s Newark and Philadelphia Field Offices,...
cfsre: Local Anesthetics (Lidocaine and other ‘Caines): Toxic Adulterants Found in Illicit Street Drugs

Substance use disorder treatment providers, clinicians, outreach workers, and public health agencies should be aware of the following information.
The Center for Forensic Science Research & Education (CFSRE) released an adulterant alert about diphenhydramine (Benadryl), with recommendations for...